Nanologica AB (publ) EBIT

The latest EBIT for NICA.ST is $-54M as of June 2026. That compares with $-54M in the prior-year period — down 0.3% year over year. That is below the sector sector average of $2.5T. Investors often review this figure alongside Nanologica AB (publ)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, NICA.ST's EBIT moved from $-54M to $-54M — a 0.3% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Nanologica AB (publ)'s operating scale or balance-sheet position.

Against its sector companies, NICA.ST currently prints $-54M for EBIT, while the sector average sits near $2.5T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Nanologica AB (publ)'s growth, margins, and balance sheet.

A EBIT figure of $-54M for NICA.ST is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $2.5T. Explore the charts below for those layers of context.

After noting NICA.ST's EBIT ($-54M), review year-over-year change from $-54M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.